Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

NCT00788125 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class

Stopped Terminated early due a shift in resources after lackluster performance of the drug.

Conditions

Interventions

Sponsor

City of Hope Medical Center

Collaborators